Capital International Inc’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-157,896
Closed -$5.6M 315
2025
Q2
$5.6M Sell
157,896
-113,231
-42% -$3.67M 0.05% 209
2025
Q1
$9.2M Sell
271,127
-310,249
-53% -$11.1M 0.11% 174
2024
Q4
$18.9M Buy
581,376
+10,864
+2% +$450K 0.22% 119
2024
Q3
$27.8M Buy
570,512
+38,852
+7% +$2.07M 0.35% 81
2024
Q2
$23.5M Buy
531,660
+77,996
+17% +$3.6M 0.31% 91
2024
Q1
$25.4M Buy
453,664
+21,448
+5% +$1.29M 0.34% 89
2023
Q4
$26M Sell
432,216
-28,820
-6% -$1.83M 0.41% 72
2023
Q3
$31M Sell
461,036
-27,721
-6% -$1.93M 0.59% 45
2023
Q2
$33.7M Sell
488,757
-15,763
-3% -$1.03M 0.61% 47
2023
Q1
$24.3M Sell
504,520
-56,357
-10% -$2.76M 0.49% 63
2022
Q4
$28M Sell
560,877
-683,485
-55% -$33.1M 0.6% 44
2022
Q3
$50.8M Buy
1,244,362
+7,891
+0.6% +$370K 1.13% 21
2022
Q2
$68M Sell
1,236,471
-526,619
-30% -$22.2M 0.94% 28
2022
Q1
$64.1M Sell
1,763,090
-180,627
-9% -$7.14M 0.72% 46
2021
Q4
$90.6M Buy
1,943,717
+23,851
+1% +$1.21M 0.84% 27
2021
Q3
$97.1M Sell
1,919,866
-31,979
-2% -$1.33M 0.94% 25
2021
Q2
$80.1M Buy
1,951,845
+35,000
+2% +$1.19M 0.71% 43
2021
Q1
$55.6M Hold
1,916,845
0.52% 65
2020
Q4
$54M Sell
1,916,845
-102,111
-5% -$2.94M 0.5% 70
2020
Q3
$62.3M Hold
2,018,956
0.69% 44
2020
Q2
$85.9M Buy
+2,018,956
New +$78.9M 1.05% 23

Other funds holding LEGN

Capital International Inc's LEGN Position: Q3 2025 in Review

Capital International Inc sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 157,896 shares — an estimated $5.6M sold.

Capital International Inc first reported a position in LEGN in Q2 2020 and held it in 21 quarters. The position peaked at $97.1M in Q3 2021. 199 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • Capital International Inc reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • Capital International Inc sold 157,896 Legend Biotech shares in Q3 2025, an estimated $5.6M.
  • Capital International Inc first reported a position in Legend Biotech in Q2 2020 and held it in 21 quarters.
  • Capital International Inc's Legend Biotech position peaked at $97.1M in Q3 2021.
  • 199 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on Capital International Inc's 13F filing for Q3 2025, filed 13 Nov 2025.